Although we did not perform endomyocardial biopsies, non‐invasive assessments, including CMR, TTE, and ECG, supported this finding, consistent with prior studies in which elevated cTnT levels were found in skeletal myopathies without corresponding cTnI elevation [30, 31, 32]. The gene discussed is TNNI3; the disease is skeletal muscle disorder.